流出
生物发生
钾
血小板
化学
线粒体
线粒体生物发生
细胞生物学
生物化学
生物
医学
内科学
基因
有机化学
作者
Qihao Chen,Sou Nakamura,Takuya Yamamoto,Naoya Takayama,Naoshi Sugimoto,Koji Eto
标识
DOI:10.1016/j.jtha.2025.05.013
摘要
Background Potassium ions (K + ) are essential for platelet function, yet their role in thrombopoiesis—particularly through specific K + channels—remains poorly understood. This gap is especially relevant in the context of in vitro platelet production from induced pluripotent stem cell (iPSC)–derived immortalized megakaryocyte progenitor cell lines (imMKCLs), which we developed for clinical-grade platelet manufacturing. Objectives We aimed to elucidate how K + channels contribute to platelet biogenesis, focusing specifically on the calcium ion (Ca 2+ )-activated K + channel KCNN4 (also known as K Ca 3.1). Methods Using imMKCLs and human cord blood (CB)–derived megakaryocytes, we analyzed intracellular cation dynamics during platelet production. RNA sequencing profiling was conducted to identify K + channel gene expression changes, focusing on KCNN4 . Its role in proplatelet formation and platelet release was examined using pharmacologic inhibitors and gene knockdown. We further investigated the link between KCNN4 and microtubule organization, mitochondrial function, and reactive oxygen species (ROS) levels. Results A progressive decline in intracellular K + concentration ([K + ]ᵢ) was observed during the 6-day maturation period of imMKCLs. KCNN4 was upregulated at onset of platelet generation, and its inhibition or knockdown led to impaired proplatelet formation and reduced platelet yield in both imMKCLs and CB–derived megakaryocytes. These effects were accompanied by decreased [K + ]ᵢ, reduced mitochondrial membrane potential (MMP), and increased ROS accumulation. Conclusion Our findings reveal that the KCNN4-mediated reduction in [K + ]ᵢ is a crucial mechanism linking cytoskeletal reorganization, mitochondrial function, and ROS homeostasis to effective thrombopoiesis. This study provides new insights into platelet biogenesis and offers potential avenues to optimize ex vivo platelet production.
科研通智能强力驱动
Strongly Powered by AbleSci AI